LKT Labs

Biochemicals for Life Science Research

Tofacitinib Citrate

Tofacitinib Citrate

Product ID T5720
Cas No. 540737-29-9
Purity ≥99%
Product Unit SizeCostQuantityStock
5 mg $93.60 In stock
25 mg $401.30 In stock
100 mg $1,471.60 In stock
Bulk Quote

Quicklinks

Description

Tofacitinib is an inhibitor of JAK1/2/3 that is clinically used to treat myelofibrosis and rheumatoid arthritis. Tofacitinib exhibits immunosuppressive, anti-inflammatory, and antiviral activities. In vitro, tofacitinib inhibits production of inflammatory cytokines, Th2 cell differentiation, Th17 cell differentiation, and activation of STAT1, which in turn prevents induction of T-bet and generation of Th1 cells. In other cellular models, tofacitinib inhibits HIV replication and reactivation of latent HIV-1.

Product Info

Cas No.

540737-29-9
Purity

≥99%
Formula

C16H20N6O • C6H8O7
Formula Wt.

504.49
Chemical Name

3-[(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropanenitrile citrate salt
IUPAC Name

2-hydroxypropane-1,2,3-tricarboxylic acid;3-[(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropanenitrile
Synonym

CP-690550-10, Tasocitinib citrate salt
Solubility

Soluble in DMSO (100 mg/ml at 25 °C), ethanol (<1 mg/ml at 25 °C), DMF (~5 mg/ml), water (<1 mg/ml at 25 °C), and 0.5% methylcellulose (30 mg/ml at 25 °C)
Appearance

White to off white powder

Shipping and Storage

Store Temp

Ambient
Ship Temp

Ambient

Downloads

MSDS

T5720 MSDS PDF
Info Sheet

T5720 Info Sheet PDF

References

Gavegnano C, Detorio M, Montero C, et al. Ruxolitinib and Tofacitinib are Potent and Selective Inhibitors of HIV-1 Replication and Virus Reactivation in Vitro. Antimicrob Agents Chemother. 2014 Jan 13. [Epub ahead of print]. PMID: 24419350.

Yamaoka K, Tanaka Y. Targeting the Janus kinases in rheumatoid arthritis: focus on tofacitinib. Expert Opin Pharmacother. 2014 Jan;15(1):103-13. PMID: 4188100.

Tak PP, Kalden JR. Advances in rheumatology: new targeted therapeutics. Arthritis Res Ther. 2011 May 25;13 Suppl 1:S5. PMID: 21624184.

Ghoreschi K, Jesson MI, Li X, et al. Modulation of innate and adaptive immune responses by tofacitinib (CP-690,550). J Immunol. 2011 Apr 1;186(7):4234-43. PMID: 21383241.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • E6397

    EPZ6438

    EZH2 HMT inhibitor. It induces regression in malig...
    ≥99%
  • E6814

    Erdosteine

    Thiol derivative, antioxidant.
    ≥98%
  • F4503

    Flavokawain B

    Chalcone kavalactone that suppresses inflammation ...
    ≥97%
  • Z161022

    α-Zearalanol

    α-Zearalanol is a mycotoxin that has structural s...
    ≥98%
  • B3573

    Bisdemethoxycurcumin

    Curcumin derivative; DNMT1 and α-amylase inhibito...
    ≥98%
  • A4930

    7-Aminoactinomycin D

    Actinomycin derivative used to study apoptosis and...
    ≥97%
  • R2713

    Recombinant HCV-NS4 Antigens

    Recombinant HCV antigen fragment.
    ≥95%
  • A3208

    AICAR

    AMPK activator.
    ≥98%
  • P4782

    PluriSIn 1

    Stearoyl-coA desaturase 1 inhibitor.
    ≥98%
  • E5576

    Entecavir

    Nucleoside (deoxyguanosine) analog; DNA chain term...
    ≥97%
  • C9708

    CYC-116

    AurKB/C inhibitor.
    ≥98%
  • A5276

    Angiotensin I, human

    Endogenous peptide, cleavage product of angiotensi...
    ≥98%
  • B6811

    [Tyr8]-Bradykinin

    Natriuretic, vasodilatory peptide, bradykinin anal...
    ≥95%
  • R3220

    Rifampicin

    Ansamycin; bacterial DNA-dependent RNA polymerase ...
    ≥98%
  • E4912

    EMD 1214063

    c-MET inhibitor.
    ≥99%
  • T7860

    TTP 22

    Casein kinase 2 inhibitor.
    ≥98%
  • F4781

    Fludarabine

    Nucleoside (adenosine) analog; DNA chain terminato...
    ≥98%
  • E6376

    Eptifibatide

    Glycoprotein IIb/IIIa inhibitor.
    ≥98%
  • L5660

    Loperamide Hydrochloride

    FIASMA, μOR agonist, potential HCN channel blocke...
    ≥98%
  • M2400

    MG-132

    Proteasome inhibitor.
    ≥98%